Financhill
Back

Ligand Pharmaceuticals 10K Form

Sell
45

LGND
Ligand Pharmaceuticals

Last Price:
71.28
Seasonality Move:
5.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive LGND News And Ratings

See the #1 stock for the next 7 days that we like better than LGND

LGND Financial Statistics

Sales & Book Value

Annual Sales: $131.31M
Cash Flow: $-42.68M
Price / Cash Flow: 0
Annual Sales: $39.92
Price / Book: 1.8

Profitability

EPS (TTM): 2.90000
Net Income (TTM): $52.15M
Gross Margin: $120.8M
Return on Equity: 7.96%
Return on Assets: 6.71%

Ligand Pharmaceuticals Earnings Forecast

Key Ligand Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 30 years for LGND is 91.99%.
  • The Selling, General & Administrative Expenses for LGND have been equal to 40.20% of Gross Profit Margin.
  • The Research & Development expenses have been 18.69% of Revenue.
  • The Interest Expense is 1.26% of Operating Income.
  • The Net Earning history of LGND is 39.72% of Total Revenues.
  • Per Share Earnings over the last 30 years have been positive in 19 years.

Ligand Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: LGND
CUSIP: 53220K
Website: ligand.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 14.15
Quick Ratio: 12.49

Price-to-Earnings

Trailing P/E Ratio: 24.24
Forward P/E Ratio: 12.72

LGND Technical Analysis vs Fundamental Analysis

Sell
45
Ligand Pharmaceuticals (LGND) is a Sell

Is Ligand Pharmaceuticals a Buy or a Sell?